Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
This analysis highlights how long-term returns vary across index funds, emphasizing the impact on portfolio resilience.
28,357 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Walmart raises its payout to 0.99 per share, extending a 53-year dividend-raising streak and keeping Dividend King st...
The Biden administration filed an antitrust suit against a meat-industry data firm accused of aiding price increases,...
Defense technology is approaching a market shakeout as government procurement reforms accelerate purchases and ventur...
A prominent follower of Buffett’s value approach argues for a side hustle that can replace a salary, not a sudden qui...
As refined product margins surge, a veteran energy analyst says the bottleneck is refining capacity, not crude supply...
Real estate professionals say the pressure to stay on call 24/7 is costing more than time—it’s undermining burnout, d...
Delinquencies eased in March to 3.35%, though higher-severity stress remains elevated. FHA loans push delinquency sha...
A Social Security review shows thousands of widows lose six figures by claiming survivor benefits at the wrong age. T...
A practical view of living on a Greek island in retirement, with budget ranges, affordable island options, and health...
Public dating moments, from Broadway nights to kiss moments, can shine a light on money habits and budgeting for coup...
IBM’s market collapse is forcing a reckoning on its future strategy as Microsoft and Apple deepen AI and cloud leader...